The Nomadic Scientists Of Today: Where Is Their Sense Of Loyalty?

As more researchers switch labs, concerns mount over the nature of relationships between leading scientists and their institutions Rein Saral and three of his colleagues in the bone marrow transplant program at Johns Hopkins University in Baltimore are moving to Emory University in Atlanta. Surgical oncologist David Morton and about a half-dozen other investigators at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles, have switched to other institutions throu

Written bySusan L-J Dickinson
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Although no one keeps statistics on the number of scientists who change institutions in any given year, many researchers and administrators say they are observing an increase in the incidence of these moves. It is a trend about which some are comfortable, some concerned. But virtually everyone is intrigued by the questions that such a trend raises. To what extent is a scientist a free agent? How much of this activity is stimulated by money and alleged "bidding wars" over the superstars in science? What do a principal investigator and his or her institution owe each other? And does it really matter where a scientist works?

When you get right down to it, administrators like to point out, all a scientist "owns" is his or her intellect, ideas, and creativity. Peer-review grants, though applied for and garnered by the principal investigator, are awarded to the institution. Likewise, all equipment and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies